Literature DB >> 1679335

Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse.

G L Bernardini1, X Gu, E Viscardi, D C German.   

Abstract

d-Amphetamine (d-AMP) is a potent releaser of dopamine (DA), and its central nervous system stimulant action is mediated primarily through its effect on the substantia nigra and ventral tegmental area dopaminergic neurons (nuclei A9 and A10, respectively). The purpose of the present experiment was to use electrophysiological techniques to examine dendritic release of DA in the in vitro slice preparation, and determine whether: (1) d-AMP inhibits the firing rates of both A9 and A10 cells; (2) the d-AMP-induced inhibition is mediated via the dendritic release of DA; and (3) there is spontaneous dendritic release of DA. Superfusion with d-AMP (2-100 microM) produced identical inhibitory dose-response curves for A9 and A10 cells, and a dose of 6.25 microM caused more than 50% inhibition in the cell firing rates. The d-AMP-induced inhibition was attenuated by blocking DA synthesis. Either D2 receptor blockade (sulpiride, 1 microM), or DA synthesis inhibition (alpha-methylparatyrosine, 50 microM) resulted in a marked increase in the firing rates of dopaminergic cells. These data suggest that d-AMP comparably releases DA from both A9 and A10 cell dendrites, that it releases newly-synthesized DA to inhibit cell firing, and that DA is tonically released to regulate cell firing rates via interactions with inhibitory D2 autoreceptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679335     DOI: 10.1007/bf01244969

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  38 in total

1.  Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals.

Authors:  A Björklund; O Lindvall
Journal:  Brain Res       Date:  1975-01-17       Impact factor: 3.252

2.  Release of dopamine from dendrites in rat substantia nigra.

Authors:  L B Geffen; T M Jessell; A C Cuello; L L Iversen
Journal:  Nature       Date:  1976-03-18       Impact factor: 49.962

3.  Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat.

Authors:  M Besson; A Cheramy; P Feltz; J Glowinski
Journal:  Brain Res       Date:  1971-09-24       Impact factor: 3.252

4.  d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.

Authors:  M Raiteri; A Bertollini; F Angelini; G Levi
Journal:  Eur J Pharmacol       Date:  1975-11       Impact factor: 4.432

5.  Midbrain dopamine neurons: differential responses to amphetamine isomers.

Authors:  S Browder; D C German; P A Shore
Journal:  Brain Res       Date:  1981-03-02       Impact factor: 3.252

6.  Monoaminergic synapses, including dendro-dendritic synapses in the rat substantia nigra.

Authors:  C J Wilson; P M Groves; E Fifková
Journal:  Exp Brain Res       Date:  1977-11-24       Impact factor: 1.972

7.  A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists.

Authors:  F J White; R Y Wang
Journal:  Life Sci       Date:  1984-03-19       Impact factor: 5.037

Review 8.  Dendritic release of dopamine in the substantia nigra.

Authors:  A Cheramy; V Leviel; J Glowinski
Journal:  Nature       Date:  1981-02-12       Impact factor: 49.962

9.  Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine.

Authors:  J Glowinski; J Axelrod; L L Iversen
Journal:  J Pharmacol Exp Ther       Date:  1966-07       Impact factor: 4.030

10.  Responsiveness to 'autoreceptor' doses of apomorphine inversely correlated with the firing rate of dopaminergic A9 neurons: action of baclofen.

Authors:  G Mereu; F Muntoni; P Calabresi; F Romani; V Boi; G L Gessa
Journal:  Neurosci Lett       Date:  1986-04-11       Impact factor: 3.046

View more
  9 in total

1.  Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells.

Authors:  M E Stockton; K Rasmussen
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

2.  Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area.

Authors:  M J Nirenberg; J Chan; R A Vaughan; G R Uhl; M J Kuhar; V M Pickel
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

Review 3.  Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction.

Authors:  Natalie A Hadad; Lori A Knackstedt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-06       Impact factor: 4.530

4.  Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area.

Authors:  M J Nirenberg; J Chan; R A Vaughan; G R Uhl; M J Kuhar; V M Pickel
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

5.  Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine.

Authors:  M J Nirenberg; J Chan; Y Liu; R H Edwards; V M Pickel
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

6.  Extrastriatal dopaminergic circuits of the Basal Ganglia.

Authors:  Karen S Rommelfanger; Thomas Wichmann
Journal:  Front Neuroanat       Date:  2010-10-27       Impact factor: 3.856

7.  Modulation of midbrain dopamine neurotransmission by serotonin, a versatile interaction between neurotransmitters and significance for antipsychotic drug action.

Authors:  J E Olijslagers; T R Werkman; A C McCreary; C G Kruse; W J Wadman
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

8.  D2-Like dopamine autoreceptor activation reduces quantal size in PC12 cells.

Authors:  E N Pothos; S Przedborski; V Davila; Y Schmitz; D Sulzer
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

9.  The h-current in the substantia Nigra pars compacta neurons: a re-examination.

Authors:  Cristina Gambardella; Angela Pignatelli; Ottorino Belluzzi
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.